Line Merethe Myklebust receives support from Bergens medisinske stiftelse
Line Merethe Myklebust is awarded a research grant of 1,1 million kr per year for 3 years from Bergensk Medisinske Forskningsstiftelse, for the project N-terminal acetyltransferases in cancer - inhibitor development
Myklebust is employed at the Department of Molecular Biology, and is affiliated with the MetaSig research program and it's NAT research group.
Bergen medisinske forskningsstiftelse has as it's goal to support young, promising scientists who has finished their post doc period. The fund was established by Trond Mohn.